SCHEMBL25522341

SCHEMBL25522341

CC(C)c1c(O)cc(-c2cc(F)c3cnc(N)nc3c2)cc1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RPS6KA3 P51812 1/20 0.36
▸ DHFR P00374 1/20 0.34
▸ TEK Q02763 1/20 0.32
▸ P2RX3 P56373 2/20 0.32
▸ P2RX2 Q9UBL9 2/20 0.32
▸ JAK2 O60674 6/20 0.32
▸ JAK1 P23458 6/20 0.32
▸ TYK2 P29597 6/20 0.32
▸ KDR P35968 6/20 0.32
▸ JAK3 P52333 6/20 0.32
▸ AURKB Q96GD4 6/20 0.32
▸ VRK1 Q99986 1/20 0.31
▸ ALOX5AP P20292 2/20 0.31
▸ FEN1 P39748 2/20 0.31
▸ TLR9 Q9NR96 1/20 0.31
▸ TLR8 Q9NR97 1/20 0.31
▸ TLR7 Q9NYK1 1/20 0.31
▸ PIK3CA P42336 1/20 0.31
▸ MTOR P42345 1/20 0.31
▸ RICTOR Q6R327 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25520074 0.96 RPS6KA3 (0.36) RPS6KA3DHFRTEKP2RX3P2RX2
SCHEMBL25522055 0.85 VRK1 (0.35) RPS6KA3DHFRTEKP2RX3P2RX2
SCHEMBL27033266 0.84 JAK2 (0.33) P2RX3P2RX2JAK2JAK1TYK2
SCHEMBL30726167 0.84 JAK2 (0.33) P2RX3P2RX2JAK2JAK1TYK2
SCHEMBL27033288 0.84 JAK2 (0.33) P2RX3P2RX2JAK2JAK1TYK2
SCHEMBL31538918 0.84 JAK2 (0.33) P2RX3P2RX2JAK2JAK1TYK2
SCHEMBL25522346 0.81 CYBB (0.34) ALOX5APFEN1TLR9TLR8TLR7
SCHEMBL25522348 0.81 FEN1 (0.36) VRK1ALOX5APFEN1TLR9TLR8
SCHEMBL25522435 0.78 RPS6KA3 (0.34) RPS6KA3DHFRTEKJAK2JAK1
SCHEMBL25522440 0.76 FEN1 (0.37) VRK1ALOX5APFEN1TLR9TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023086428-A2 NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF USE THEREOF ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD. (CN) 2023-05-19 — — WO disclosed
Send feedback